L’Occitane Group will hold an 83% indirect interest in the brand, and upon closing, Sol de Janeiro will become a majority-owned subsidiary of the company.
The Vistria Group has acquired BioCare, a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy and logistics services.